Rare diseases
Investigational molecules
Locations
1 Kendall Square Building 1400w, 02139-1562, United States
Repertoire Immune Medicines Inc. is involved in clinical research focused on advanced solid tumor indications, with an emphasis on treatment approaches for difficult-to-manage cancers in the oncology setting.
The sponsor’s current clinical activity centers on therapeutic strategies that include monotherapy and combination use with anti-PD-1 monoclonal antibodies, reflecting interest in immune-based cancer treatment.
Repertoire Immune Medicines Inc. runs clinical trials in conditions such as Neoplasm, among others.
Clinical trials run by this sponsor – those enrolling participants first.
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
